Tech Company Financing Transactions
Tepha Funding Round
The Vertical Group and Novartis BioVenture Fund participated in a $4.3 million funding round for Tepha. The round was recorded on 11/22/2004.
Transaction Overview
Company Name
Announced On
11/22/2004
Transaction Type
Venture Equity
Amount
$4,300,000
Round
Undisclosed
Investors
The Vertical Group (Lead Investor)
Proceeds Purpose
The funds will be used to complete the submissions of Premarket Notification 510(k) Applications to the FDA for the Company's first products, as well as for research and development and working capital.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
99 Hayden Ave. East Wing 360
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Tepha is a medical device firm engaged in the development of a new range of absorbable devices for therapeutic applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Joiner
Chief Financial Officer
Ian Vawter
Chief Operating Officer
John Hartnett
Vice President
Lois Lombardi
VP - Manufacturing
Said Rizk
VP - R & D
David Martin
VP - Regulatory Affairs
Connie Garrison
Browse more venture capital transactions:
Prev: 11/22/2004: Transport Pharmaceuticals venture capital transaction
Next: 11/22/2004: CopperGate Communications venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs